305 related articles for article (PubMed ID: 18035322)
1. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
[TBL] [Abstract][Full Text] [Related]
2. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
Youinou P; Pers JO; Jamin C; Lydyard PM
Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
[TBL] [Abstract][Full Text] [Related]
3. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens.
Chiorazzi N; Hatzi K; Albesiano E
Ann N Y Acad Sci; 2005 Dec; 1062():1-12. PubMed ID: 16461783
[TBL] [Abstract][Full Text] [Related]
4. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
5. Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings.
Ferraccioli G; Tolusso B
Autoimmun Rev; 2007 Dec; 7(2):109-13. PubMed ID: 18035319
[TBL] [Abstract][Full Text] [Related]
6. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
Caligaris-Cappio F; Ghia P
J Clin Oncol; 2008 Sep; 26(27):4497-503. PubMed ID: 18662968
[TBL] [Abstract][Full Text] [Related]
7. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes on the front line of autoimmunity.
Youinou P; Hillion S; Jamin C; Pers JO; Saraux A; Renaudineau Y
Autoimmun Rev; 2006 Mar; 5(3):215-21. PubMed ID: 16483922
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
[TBL] [Abstract][Full Text] [Related]
10. An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL.
Dighiero G
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):283-8. PubMed ID: 3065729
[TBL] [Abstract][Full Text] [Related]
11. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
12. Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
Rosén A; Murray F; Evaldsson C; Rosenquist R
Semin Cancer Biol; 2010 Dec; 20(6):400-9. PubMed ID: 20863893
[TBL] [Abstract][Full Text] [Related]
13. The normal counterpart to the chronic lymphocytic leukemia B cell.
Caligaris-Cappio F; Ghia P
Best Pract Res Clin Haematol; 2007 Sep; 20(3):385-97. PubMed ID: 17707828
[TBL] [Abstract][Full Text] [Related]
14. The CD5+ B-cell.
Dono M; Cerruti G; Zupo S
Int J Biochem Cell Biol; 2004 Nov; 36(11):2105-11. PubMed ID: 15313456
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.
Ghia P; Chiorazzi N; Stamatopoulos K
J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179
[TBL] [Abstract][Full Text] [Related]
16. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
17. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
18. Role of the B-cell receptor in chronic lymphocytic leukemia: where do we stand?
Fais F; Bruno S; Ghiotto F
Ital J Anat Embryol; 2010; 115(1-2):79-84. PubMed ID: 21072994
[TBL] [Abstract][Full Text] [Related]
19. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Rawstron AC; Bennett F; Hillmen P
Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
